Instructions for the preparation of posters you can download here.
|
P 1 |
Validation and qualification of an isolator used for the sterile containment of toxic product
D. Meyer, Getinge Life Sciences, Vendome/F |
| P 2 |
How to control the airflow and pressure for BSL-3 facilities
|
| P 3 |
Laboratory biosafety and quality management systems in a drug discovery environment: mechanistic and synergy
T. Battle , G. Ischl, Y. Berchoux, G. Feger, Merck Serono International S.A., Geneva/CH |
| P 4 |
Perspective application from DNA based methods for investigating fungal aeroallergens
D. Davolos, B. Pietrangeli , Italian National Institute for Occupational Safety and Prevention (ISPESL), Rome/I |
| P 5 |
Potential presence of opportunistic pathogenic bacteria: molecular analysis on the biofilms of reactor sludges
D. Davolos, B. Pietrangeli , I talian National Institute for Occupational Safety and Prevention (ISPESL), Rome/I |
| P 6 |
Gene sequencing analysis on the virulent roles of the bacterial denitrifying enzymes
D. Davolos, B. Pietrangeli , Italian National Institute for Occupational Safety and Prevention (ISPESL), Rome/I |
| P 7 |
The European culture collections: initiating and giving input to cooperations on regulatory issues
D. Fritze , Ch. Rohde, DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen, Braunschweig/D |
| P 8 |
Microbial culture collections underlie and contribute to the global bioregulative framework: some examples
Ch. Rohde, D. Fritze , DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen, Braunschweig/D |
| P 9 |
Small scale area decontamination using chlorine dioxide gas generated from ready to use tablets
J. Krishnan , G. Fey, D. Gordon, S. Klassen, S. Theriault, Public Health Agency of Canada, Winnipeg/CDN |
| P 10 |
Vulnerability/risk (VR) analysis of HEPA filter system selection and the role of biosafety personnel
M. Huza, Camfil Farr Company, Columbia, Maryland, MD/USA |
| P 11 |
The public perception of biotechnology and its impact on biosafety regulations and on the development of biotechnology in Latin America L.M. Oda , K.C.A. Souza, L.H. Souza, ANBio- Brazilian Biosafety Association, Rio de Janeiro/BR |
| P 12 |
Public perception on modern biotechnology: its consequent adverse impact on regulation, police coherence, innovation, environmental and social welfare. L.M. Oda , K.C.A. Souza, L.H. Souza, ANBio- Brazilian Biosafety Association, Rio de Janeiro/BR |
| P 13 |
Development and implementation of a laboratory biosecurity programme at a overseas laboratory: a successful model for identifying and incorporating key safety, security, and reliability elements C. Wendel, US Army Medical Research and Materiel Command, Fort Detrick, MD/USA |
|
P 14 |
Remote monitoring of laboratory animals in biocontainment
V.L Savage , M.S. Lever, M Nelson, Dstl, Salisbury/UK |
|
P 15 |
Model systems for the validation of chemical decontamination of surfaces of individual protective equipment
K. Lemmer , A. Roder, R. Grunow, Center for Biological Safety (ZBS2), Robert Koch Institute, Berlin/D; M. Mielke, I. Schwebke, Applied Infection Control and Hospital Hygiene (FG 14), Robert Koch Institute, 'Berlin/D; G. Pauli, Center for Biological Safety, Robert Koch Institute, Berlin/D; H. Nattermann, Center for Biological Safety (ZBS2), Robert Koch Institute, Berlin/D |
|
P 16 |
Will they fit?
In vivo
testing of FFP3 respirators in a biosafety environment
G.F. Lichtfuss, W. Biederbick, C. Bartels , Robert Koch-Institut, Berlin/D |
|
P 17 |
Actual pressure changes in protective clothing
K. Shinohara , National Institute of Infectious Diseases Japan, Musashimurayama-shi Tokyo/J; H. Nagasawa, K. Satoh, SHIGEMATSU WORK Co., Ltd., Tokyo/J; S. Kumagai, AZEARTH Co., Tokyo/J; N. Shimazaki, National Institute of Infectious Diseases Japan, Tokyo/J |
|
P 18 |
Methods for measuring the sealability of microbiology containment laboratories
T. Pottage , A. Bennett, J. Mace, S. Parks, Health Protection Agency, Salisbury/UK |
|
P 19 |
Safety awareness training programme for maintenance and security personnel
M.D. Wienia, A.M. van Miltenburg, C.A. van Herk, P.T. Odinot , Utrecht University/NL |
|
P 20 |
Commissioning to the laboratory guidelines
J. Evans, G Tremblay , Merrick & Company, Atlanta, GA/USA |
|
P 21 |
Biological safety officers platform
A Dutch Association |
|
P 22 |
Belgian Biosafety Professionals: a regional working group of EBSA after 2 years … on track ! Toon De Kesel (Innogenetics), René Custers (VIB), Suzanne Loret (FUNDP), Marianne Schoukens (KULeuven) and Philippe Stroot (Xibios) |
|
P 23 |
Biosafety risk assessment Wiki
S.A. Caskey, J. Smith, J. Gaudioso , R.M. Salerno, Albuquerque, NM/USA |
|
P 24 |
Effluent decontamination systems: the challenges in design, testing, operation and biological verification
G. Tremblay , Merrick & Company, Atlanta, GA/USA; S. Jones , Progressive Recovery Inc., Dupo, IL/USA |
|
P 25 |
EBSA – BBP TransportUN Model Regulations – GMO and Plant Pathogens |
|
P 26 |
EBSA Biosafety Professional (BSP) Competency |
|
P 27 |
International Biosafety Working Group (IBWG) |
|
P 28 |
Ukrainian biosecurity & biosafety training centre
V. Pushkina, N. Popova. Ukrainian I.I Mechnikov Anti-Plague Research Institute, Ukraine; D. Doucette-Preville, Global Partnership Program, Department of Foreign Affairs and International Trade, Canada. |
| Last update 15.06.2010 Webmaster |